Research lab @UmeaUniversity, studying B cell and antibody responses to microbial infection.
Umeå, Sverige
Joined May 2019
- Tweets58
- Following64
- Followers103
- Likes63
for more information about the EC postdoc program, see nature.com/articles/d42473-0…
Postdoctoral position available to to come and work with us on furthering our understanding of infections and immunity across generation (oldest old and children) umu.se/en/ucmr/ec-postdoc-pr…
Forsell Lab retweeted
1) I feel this paper by Mattias Forsell's group is often overlooked but shows something very important: Binding antibody to SARS-CoV-2 spike - in the absence of strong neutralizing antibodies to a new variant - predict protection from mortality. thelancet.com/journals/lanep….
Vaccine-induced antibodies coupled to infection- and mortality data from 3012 older individuals (median age 86) at Swedish nursing homes. sciencedirect.com/science/ar…
From our collaboration with the Johansson lab, and others. @umeauniversity @KlingstromLab @BenjMurrell
Forsell Lab retweeted
The lab is recruiting! We're at Karolinska, in Stockholm. We're looking for:
- a postdoc with a computational/statistical background, with an interest in evolution and/or deep learning
- a few `wetlab' roles, including a postdoc ("antibody stuff"), and lab tech/admin folks. 1/n
Our new paper demonstrating the feasibility of at-home sampling to provide equal opportunities for serological testing in rural areas.
eurosurveillance.org/content…
Come join our work on studies of vaccination and infections in elderly. Collaborative postdoc project with Anders Johansson (umu) and Jochen Schwenk (SciLife, KTH)
Project 16 in the ad:
nature.com/naturecareers/job…
On the 7th of October, our first grad student Andy Dernstedt defended their thesis “Life and death of human B cells in health and disease”. Here, Andy described multiple aspects of the B cell life cycle during infection and vaccination. Congratulations on your degree! 🎓🥳
Forsell Lab retweeted
Having a PhD? Interested in epidemiological research on long-term consequences of infectious diseases?
Then we have the position for you. Please share! @medfak_LU
lupop.lu.se/article/postdoct…
Forsell Lab retweeted
Happy to share our latest publication: Anti-spike mucosal IgA protection against SARS-Cov-2 omicron infection.
Fantastic collaboration with Charlotte Thålin @SmedSorensenLab @KimBlom10 and many more!
nejm.org/doi/full/10.1056/NE…
Forsell Lab retweeted
86% efficacy for the @pfizer RSV prefusion F vaccine in the elderly is extremely good news! Looks like there will be multiple RSV vaccines available soon for this target population. Still looking forward to seeing the data later this year from their maternal vaccine trial.
Pfizer races to beat rivals GSK, J&J, Moderna for slice of $10bn respiratory jab market: will apply for approval of RSV vaccine after reporting its jab is 86% effective at preventing severe disease on.ft.com/3PO5quX
Forsell Lab retweeted
Received an email from Rino Rappuoli this morning informing me, @BarneyGrahamMD and Peter Kwong of the positive phase III data for the RSV prefusion F vaccine results in older adults. It's been almost 10 years since we designed the first prefusion RSV F antigen, DS-Cav1. Amazing!
Great work by @chengzi_kaku and @LauraMWalker2 on B cell recall after omicron/BA.1 breakthrough infection in mRNA vaccinated donors. Happy we could help out @UmeaUniversity. science.org/doi/10.1126/scii…
Forsell Lab retweeted
Happy to share latest paper at @scienceTM from our Prometheus consortium on broadly neutralizing antibodies against emerging hantaviruses from human convalescent donors. We're especially excited about one particular antibody we've identified. bit.ly/3JkMly7 1/10
Forsell Lab retweeted
Happy to see our latest #Covidvaccination study in @regionskane published in @Eurosurveillanc
Main message - booster dose necessary to maintain sufficient protection against severe disease.
@KahnFredrik
Supported by @lunduniversity @vinnovase @Vetenskapsradet
Rapid communication:
#COVID19 #vaccineeffectiveness against severe disease from #SARSCoV2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern 🇸🇪, December 2021 to March 2022
👇🏾
bit.ly/EUS2718VE
#Omicron #ba2variant #Covidvaccination
@LU_Jonas_Bjork
ALT The authors compared vaccine effectiveness against severe COVID-19 between December 2021 and March 2022 when Omicron BA.1 and BA.2 were the dominating SARS-CoV-2 variants in Scania county, Sweden. Picture: Getty images
Come join us! We're currently recruiting 1 to 2 PhD students to work with us on human immune responses to vaccination. Apply via the Umeå University website.
umu.se/en/work-with-us/open-…
Forsell Lab retweeted
A synopsis of some of our recent hantavirus work
hsc.unm.edu/news/2022/04/res…